Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sphenopalatine Ganglion Block for Treating Acute Frontal Migraine Headache in Pediatric Patients

NCT03984045 is registered in ClinicalTrials.gov with Newark Beth Israel Medical Center as lead sponsor.

NCT NCT03984045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03984045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sphenopalatine Ganglion Block for Treating Acute Frontal Migraine Headache in Pediatric Patients
Lead sponsor
Newark Beth Israel Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
June 6, 2019
Completion date
December 30, 2022
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine in adolescence, migraine in children, sphenopalatine neuralgia